JP2017505897A5 - - Google Patents

Download PDF

Info

Publication number
JP2017505897A5
JP2017505897A5 JP2016528246A JP2016528246A JP2017505897A5 JP 2017505897 A5 JP2017505897 A5 JP 2017505897A5 JP 2016528246 A JP2016528246 A JP 2016528246A JP 2016528246 A JP2016528246 A JP 2016528246A JP 2017505897 A5 JP2017505897 A5 JP 2017505897A5
Authority
JP
Japan
Prior art keywords
level
subject
udp
glucose
inflammation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016528246A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017505897A (ja
JP6612749B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/064525 external-priority patent/WO2015070001A2/en
Publication of JP2017505897A publication Critical patent/JP2017505897A/ja
Publication of JP2017505897A5 publication Critical patent/JP2017505897A5/ja
Priority to JP2019198133A priority Critical patent/JP6898417B2/ja
Application granted granted Critical
Publication of JP6612749B2 publication Critical patent/JP6612749B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016528246A 2013-11-07 2014-11-07 炎症を検出および／または処置するための組成物および方法 Active JP6612749B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2019198133A JP6898417B2 (ja) 2013-11-07 2019-10-31 炎症を検出および／または処置するための組成物および方法

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201361962476P 2013-11-07 2013-11-07
US61/962,476 2013-11-07
US201461931184P 2014-01-24 2014-01-24
US201461931146P 2014-01-24 2014-01-24
US61/931,146 2014-01-24
US61/931,184 2014-01-24
PCT/US2014/064525 WO2015070001A2 (en) 2013-11-07 2014-11-07 Compositions and methods for detecting and/or treating inflammation

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019198133A Division JP6898417B2 (ja) 2013-11-07 2019-10-31 炎症を検出および／または処置するための組成物および方法

Publications (3)

Publication Number Publication Date
JP2017505897A JP2017505897A (ja) 2017-02-23
JP2017505897A5 true JP2017505897A5 (cg-RX-API-DMAC7.html) 2017-12-14
JP6612749B2 JP6612749B2 (ja) 2019-11-27

Family

ID=53042330

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016528246A Active JP6612749B2 (ja) 2013-11-07 2014-11-07 炎症を検出および／または処置するための組成物および方法
JP2019198133A Active JP6898417B2 (ja) 2013-11-07 2019-10-31 炎症を検出および／または処置するための組成物および方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2019198133A Active JP6898417B2 (ja) 2013-11-07 2019-10-31 炎症を検出および／または処置するための組成物および方法

Country Status (6)

Country Link
US (5) US9891236B2 (cg-RX-API-DMAC7.html)
EP (1) EP3066472B1 (cg-RX-API-DMAC7.html)
JP (2) JP6612749B2 (cg-RX-API-DMAC7.html)
AU (2) AU2014346641B2 (cg-RX-API-DMAC7.html)
CA (1) CA2929974A1 (cg-RX-API-DMAC7.html)
WO (1) WO2015070001A2 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015070001A2 (en) 2013-11-07 2015-05-14 The General Hospital Corporation Compositions and methods for detecting and/or treating inflammation
CA3018365A1 (en) 2016-03-23 2017-09-28 The General Hospital Corporation Assays and methods for detecting udp-glucose
US20210121451A1 (en) * 2018-04-16 2021-04-29 Kantum Pharma, Inc. Methods of monitoring, treating, and preventing renal inflammation associated with kidney transplantation
WO2019204289A1 (en) * 2018-04-18 2019-10-24 Kantum Diagnostics, Inc. Methods of monitoring treating, and preventing renal inflammation following cardiac procedures or events
US20210113544A1 (en) * 2018-04-30 2021-04-22 Kantum Pharma, Inc. Methods of monitoring, treating, and preventing renal inflammation associated with infection
WO2019226750A1 (en) * 2018-05-23 2019-11-28 Kantum Diagnostics, Inc. Methods of treating and preventing renal inflammation by inhibiting udp-hexose signaling
WO2019236777A1 (en) * 2018-06-08 2019-12-12 Kantum Diagnostics, Inc. Methods of monitoring, treating, and preventing renal inflammation associated with nephrotoxicity
EP3955907A4 (en) * 2019-04-16 2022-12-28 Kantum Pharma, Inc. PHARMACEUTICAL FORMULATIONS CONTAINING P2Y14 ANTAGONISTS
US11708346B2 (en) 2019-07-23 2023-07-25 Saint Louis University Treatment and prevention of neuropathic pain with P2Y14 antagonists

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4551460A (en) * 1982-05-10 1985-11-05 Hoffmann-La Roche Inc. Pyrido[2,1-b]quinazoline derivatives useful as agents for treatment of allergic conditions and vascular disorders involving thrombosis
US5358937A (en) * 1989-01-30 1994-10-25 Institut Pasteur Glycosyl phospholipid derivatives of nucleosides and their use as medicines
WO2001093930A1 (en) * 2000-06-02 2001-12-13 The University Of Utah Research Foundation Active needle devices with integrated functionality
AU2003210382A1 (en) 2002-03-13 2003-09-22 Bayer Aktiengesellschaft Diagnostic for diseases associated with g-protein coupled receptor 105 (gpr105)
US6916802B2 (en) * 2002-04-29 2005-07-12 Genzyme Corporation Amino ceramide-like compounds and therapeutic methods of use
AU2003300776A1 (en) * 2002-09-09 2004-05-25 Omeros Corporation G protein coupled receptors and uses thereof
WO2007020935A1 (ja) * 2005-08-17 2007-02-22 Ono Pharmaceutical Co., Ltd. Ｐ２ｙ１２受容体および／またはｐ２ｙ１４受容体ブロッカーを含有してなる疼痛治療剤
JP2010531307A (ja) 2007-06-28 2010-09-24 メルク フロスト カナダ リミテツド Ｇｐｒ１０５活性のアンタゴニストとしての置換縮合ピリミジン
AU2008331417A1 (en) 2007-12-04 2009-06-11 Merck Frosst Canada Ltd Substituted 2-naphthoic acids as antagonists of GPR105 activity
EP2750676B1 (en) 2011-08-30 2018-01-10 University of Utah Research Foundation Methods and compositions for treating nephrogenic diabetes insipidus
WO2015070001A2 (en) 2013-11-07 2015-05-14 The General Hospital Corporation Compositions and methods for detecting and/or treating inflammation

Similar Documents

Publication Publication Date Title
JP2017505897A5 (cg-RX-API-DMAC7.html)
JP2017524130A5 (cg-RX-API-DMAC7.html)
JP2010516678A5 (cg-RX-API-DMAC7.html)
BR112014006741A2 (pt) método para monitorização, diagnóstico e/ou prognóstico de lesão renal aguda no estágio inicial
NZ701807A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
JP2014521089A5 (cg-RX-API-DMAC7.html)
JP2012211908A5 (cg-RX-API-DMAC7.html)
MX2018012580A (es) Métodos y kits para el diagnóstico y la estratificación de riesgo en pacientes con isquemia.
WO2014201516A3 (en) Biomarker identification
JP2011177182A5 (cg-RX-API-DMAC7.html)
JP2013511735A5 (cg-RX-API-DMAC7.html)
BR112013019563A2 (pt) métodos para prognóstico de ferida, para tratamento de ferida, para prognosticar se um paciente pode ser responsivo ao tratamento de uma ferida que exsuda um fluido de ferida, e para tratar uma ferida que exsuda um fluido de ferida, dispositivo para medir simultaneamente ou sequencialmente os níveis de hne e de pelo menos uma mmp em uma amostra de fluido de ferida, aparelho para diagnóstico, e, estojo.
JP2014144959A5 (cg-RX-API-DMAC7.html)
WO2020055954A3 (en) Methods for detecting liver diseases
RU2016107954A (ru) Способы идентификации и прогнозирования риска сердечно-сосудистого события или заболевания, или смертельного исхода, способы оценки тяжести и мониторинга сердечно-сосудистого события или заболевания, способ мониторинга эффективности терапии
NZ594772A (en) Diagnosis and prognosis of renal injury and renal failure using vitamin k dependent protein c
JP2017500584A5 (cg-RX-API-DMAC7.html)
WO2015049390A3 (en) Kidney disease biomarker
JP2018004657A5 (cg-RX-API-DMAC7.html)
JP2017508144A5 (cg-RX-API-DMAC7.html)
JP2016528914A5 (cg-RX-API-DMAC7.html)
Arslan et al. Importance of endothelial dysfunction biomarkers in patients with Crimean‐Congo hemorrhagic fever
JP2010526995A5 (cg-RX-API-DMAC7.html)
RU2016147122A (ru) Применение серелаксина для снижения gdf-15
WO2014153232A3 (en) Methods and compositions for diagnosing preeclampsia